Definium Therapeutics, Inc. (DFTX): Total Liabilities
$107.77M
As of 2025-12-31
$194.22M
As of 2026-06-30
+78.1%
3-year compound annual growth
+80.3%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $107.77M | +77.5% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $60.70M | +30.8% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $46.41M | +143.3% | 2025-03-06, Balance as of period end |
| 2022-12-31 | $19.08M | +54.6% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $12.34M | +118.3% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $5.65M | n/a | 2022-03-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | 2025-12-31 | $107.77M | +77.5% |
| Jushi Holdings Inc. (JUSH) | 2025-12-31 | $537.69M | +9.6% |
| Glass House Brands Inc. (GLAS) | 2025-12-31 | $143.96M | -1.7% |
| USANA Health Sciences Inc (USNA) | 2026-01-03 | $156.64M | -3.2% |
| Ascend Wellness Holdings, Inc. (AAWH) | 2025-12-31 | $954.55M | +15.2% |
| Marimed Inc. (MRMD) | 2025-12-31 | $137.83M | +6.5% |
| Cronos Group Inc. (CRON) | 2025-12-31 | $54.18M | -2.1% |
| Cresco Labs Inc. (CRLBF) | 2025-12-31 | $944.80M | -2.3% |
| Natural Alternatives International Inc (NAII) | 2025-06-30 | $83.51M | +4.7% |
Compare DFTX, JUSH, GLAS, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗